Characterization of the E138K resistance mutation in HIV-1 reverse transcriptase conferring susceptibility to etravirine in B and non-B HIV-1 subtypes.

Asahchop, Eugene L; Oliveira, Maureen; Wainberg, Mark A; Brenner, Bluma G; Moisi, Daniela; Toni, Thomas d'Aquin; Tremblay, Cecile L

Asahchop, Eugene L; Oliveira, Maureen; Wainberg, Mark A; Brenner, Bluma G; Moisi, Daniela; Toni, Thomas d'Aquin; Tremblay, Cecile L.

Affiliation

Asahchop EL; McGill University AIDS Centre, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.

Antimicrob Agents Chemother ; 55(2): 600-7, 2011 Feb.

Article in En | MEDLINE | ID: mdl-21135184

Subject(s)

Anti-HIV Agents/pharmacology; Drug Resistance, Viral/genetics; HIV Reverse Transcriptase/genetics; HIV-1/drug effects; Mutation; Pyridazines/pharmacology; Amino Acid Sequence; Cell Line; HIV Infections/virology; HIV Reverse Transcriptase/chemistry; HIV-1/classification; HIV-1/enzymology; HIV-1/genetics; Humans; Microbial Sensitivity Tests/methods; Molecular Sequence Data; Nitriles; Pyrimidines; Sequence Alignment

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridazines / HIV-1 / Anti-HIV Agents / Drug Resistance, Viral / HIV Reverse Transcriptase / Mutation Limits: Humans Language: En Journal: Antimicrob Agents Chemother Year: 2011 Type: Article Affiliation country: Canada

Fulltext

XML

PubMed Links

Search on Google